AI In Oncology: Advancements In Managing And Monitoring Cancer Treatment Side Effects

  |   Artificial Intelligence   |   No comment

How AI is Revolutionizing Cancer Treatment

Artificial Intelligence’s expanding use in cancer care has led to remarkable breakthroughs thanks to advanced data processing and analysis. Specifically, AI algorithms significantly help radiologists detect cancerous tumors early, enabling tailored and accurate treatment plans. Additionally, AI is a game-changer in cancer research, creating better prediction models to guide doctors. By synthesizing diverse data types – from genomics and proteomics to patient records – AI improves decision-making, boosts risk evaluation, and promotes evidence-based care for cancer patients.


Understanding the Side Effects of Cancer Treatment: A Medical Viewpoint

Cancer treatments often result in various side effects, ranging from reduced energy, nausea, and hair loss, to changes in digestion, cognitive difficulties, weakened immunity, skin problems, and loss of appetite. Prolonged treatment typically leads to psychological stress or trauma. Doctors also acknowledge potential risks such as secondary cancer, infertility, heart disease, lung damage, and organ failure. Extensive chemotherapy can lower white blood cell counts (Neutropenia), and radiation can cause severe swelling like Lymphedema.


AI and Cancer: An Overview of Current Applications

AI has greatly assisted in the laborious and complex task of manually contouring organs and tumors, with Machine Learning (ML) automating this process in radiotherapy. Deep Learning (DL) techniques have advanced auto-segmentation in cancers like squamous cell carcinoma of the head and neck, and similar strategies have been applied in prostate, lung, and breast cancers, saving critical operation time. AI also accurately predicts recurrence patterns in severe cases like cervical tumors.


Today, sophisticated AI platforms optimize effectiveness in cancer diagnostic imaging, covering key procedures such as mammogram interpretation, colon polyp identification, and glioma classification. This enhances standard management for rare cancers like Central Nervous System (CNS) tumors with poor prognosis. Intelligent algorithms like Convolutional Neural Networks (CNN) reduce workload and false positives in screenings.


AI is now used to isolate circulating tumor cells and analyze specific biomarkers, improving the detection of CNS neoplasms. AI-enhanced radionics allows non-invasive tumor characterization through histopathologic classification. Using CNNs, DL-based radionics analyzes images at the pixel level, learning in cascading ways without predefined features, demanding large data sets. 


As a result, the AI models offer valuable insights, reduce redundancies and prevent overfitting. Advanced AI algorithms, like Multivariate Logistic Regression Models and Decision Trees, distinguish between primary brain tumors, primary CNS lymphoma, and brain metastases. Furthermore, AI algorithms assess critical factors like chemical sensitivity and oncogenetic mutation profiles.


The Rise of AI in Managing Cancer Treatment Side Effects

Dealing with cancer treatment side effects is often challenging, largely due to the limitations of simple statistics that fail to consider complex imaging and genomic data. However, with the introduction of Explainable AI (XAI), AI is poised to identify patients at high risk of side effects. This could encourage a collaborative approach between doctors and patients, promoting shared decision-making. 


Furthermore, AI can precisely analyze patient lifestyle patterns to mitigate side effects, integrating areas like computing, radiation oncology, medical physics, genetics, psychology, and health economics for enhanced transparency.


Real-World Cases: AI Uses in Tracking Side Effects

The effectiveness of AI in managing side effects is demonstrated in multidisciplinary treatment approaches for severe cases such as breast and prostate cancer. Using long-term data and vast databases, AI models can analyze patient anatomical features to predict side effect outcomes accurately. A notable example is the University of Illinois Chicago’s development of an AI system to evaluate patient responses to treatments efficiently. 


Another instance is a study by The Royal Marsden NHS Foundation Trust, The Institute for Cancer Research (ICR), and Imperial College London, further showcasing AI’s value in identifying cancer treatment side effects. The union of Big Data and AI has been instrumental in mitigating cancer therapy side effects, mainly through personalized treatment. A pertinent real-world application is a collaboration between Chicago-based AI and precision medicine firm Tempus and Cedars Sinai Cancer, aiming to create molecular twins to neutralize side effects in cancer treatment.


Challenges and Considerations in Using AI for Side Effect Management

The main hurdle in using AI to manage side effects is the scarcity of high-quality medical data. While there’s a lack of scholarly proof to support AI’s effectiveness, incorporating AI solutions into clinical workflows can be difficult in healthcare settings. 


Further, some AI tools lack accountability, interpretability, and transparency in data handling and predictions, leading to unclear side effect mitigation. Moreover, biased results and a lack of global standardization can give rise to regulatory and ethical issues in side effect management.


Future Prospects: The Revolutionary Impact of AI on Cancer Care

The future of AI in cancer care looks promising, driven by increased data sharing and resulting research across the medical and life sciences sector. However, finding the right equilibrium between a clinician’s judgment and AI’s outcomes is a key challenge. While radiologists’ and pathologists’ observations have often been considered infallible “gold standards”, they can sometimes lead to superficial and incorrect results. An inclusive and complementary approach seems vital. 


As top global institutions like the Department of Health and Social Care, the US Food and Drug Administration, and the UK’s National Health Service Trusts aim to regulate and guide AI usage, healthcare is on the brink of integrating computer science and medical training to explore new frontiers in AI-enhanced oncology.

No Comments

Post A Comment